Evidence map›Paper›PMID 2413446›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1985

Mapping the cysteine residues and actin-binding regions of villin by using antisera to the amino and carboxyl termini of the molecule.

P Matsudaira, R Jakes, L Cameron, E Atherton

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1985. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Protein footprinting at cysteines: probing ATP-modulated contacts in cysteine-substitution mutants of yeast DNA topoisomerase II.Proceedings of the National Academy of Sciences of the United States of America · 1999
    Article
  2. A method for probing the topography and interactions of proteins: footprinting of myoglobin.Proceedings of the National Academy of Sciences of the United States of America · 1995
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Villin sequence and peptide map identify six homologous domains.Proceedings of the National Academy of Sciences of the United States of America · 1988
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

P Matsudaira
R Jakes
L Cameron
E Atherton

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peptide antisera specific for either the amino- or carboxyl-terminal regions of villin were used to locate the position of cysteine residues in immunoblots of villin cleaved with 2-nitro-5-thiocyanobenzoic acid. Maps constructed from the cleavage pattern suggest that villin contains six cysteine residues, two located in its amino-terminal peptide of Mr 44,000, and four located in the carboxyl-terminal peptide of Mr 51,000. Gel overlays of the partial cleavage fragments with 125I-labeled actin identified a calcium-dependent actin-binding region located within the amino-terminal peptide of Mr 32,000 of villin. The peptide antibody method used, called cleavage mapping, should be a convenient technique for mapping residues and ligand binding sites in proteins.

Indexed as

ActinsAnimalsCalcium-Binding ProteinsCarrier ProteinsChickensDithionitrobenzoic AcidEpitheliumEpitopesImmune SeraIntestinal MucosaMicrofilament ProteinsMolecular WeightPeptide FragmentsActinsCalcium-Binding ProteinsCarrier ProteinsDithionitrobenzoic AcidEpitopesImmune SeraMicrofilament ProteinsPeptide Fragmentsvillin

Identifiers

PMID2413446
PMCPMC390772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.